Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.

Yan SS, Schreckenberger PC, Zheng X, Nelson NA, Harrington SM, Tjhio J, Fedorko DP.

Diagn Microbiol Infect Dis. 2008 Oct;62(2):205-9. doi: 10.1016/j.diagmicrobio.2008.04.018. Epub 2008 Jun 12.

2.

Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.

Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.

J Antimicrob Chemother. 2009 May;63(5):886-94. doi: 10.1093/jac/dkp057. Epub 2009 Mar 11.

PMID:
19279051
3.

Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.

Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA.

J Infect Dis. 2005 Apr 15;191(8):1272-9. Epub 2005 Mar 7.

PMID:
15776373
4.

Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy.

Petrelli D, Di Luca MC, Prenna M, Bernaschi P, Repetto A, Vitali LA.

Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):241-4. doi: 10.1007/s10096-013-1950-5. Epub 2013 Sep 5.

PMID:
24002218
5.

High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.

Lin JN, Chang LL, Lai CH, Huang YH, Chen WF, Yang CH, Hsu J, Lin HH, Chen YH.

Diagn Microbiol Infect Dis. 2015 Oct;83(2):187-92. doi: 10.1016/j.diagmicrobio.2015.06.018. Epub 2015 Jun 30.

PMID:
26234479
6.

Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.

Smeesters PR, Vergison A, Junior DC, Van Melderen L.

Int J Antimicrob Agents. 2009 Jul;34(1):44-9. doi: 10.1016/j.ijantimicag.2009.01.012. Epub 2009 Mar 6.

PMID:
19269141
7.

Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.

Pinho MD, Melo-Cristino J, Ramirez M; Portuguese Group for the Study of Streptococcal Infections.

Antimicrob Agents Chemother. 2010 May;54(5):1769-77. doi: 10.1128/AAC.01377-09. Epub 2010 Feb 9.

8.

Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.

Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S.

J Antimicrob Chemother. 2012 Nov;67(11):2602-5. doi: 10.1093/jac/dks281. Epub 2012 Jul 19.

PMID:
22815354
9.

In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.

Billal DS, Fedorko DP, Yan SS, Hotomi M, Fujihara K, Nelson N, Yamanaka N.

J Antimicrob Chemother. 2007 Jan;59(1):28-34. Epub 2006 Oct 25.

PMID:
17065188
10.

Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.

Montanari MP, Tili E, Cochetti I, Mingoia M, Manzin A, Varaldo PE.

Microb Drug Resist. 2004 Fall;10(3):209-17.

PMID:
15383164
11.

Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.

Powis J, McGeer A, Duncan C, Goren R, de Azavedo JC, Bast DJ, Pong-Porter S, Mazzulli T, Green K, Willey B, Low DE.

Antimicrob Agents Chemother. 2005 May;49(5):2130-2.

12.

Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.

Albertí S, Cortés G, García-Rey C, Rubio C, Baquero F, García-Rodríguez JA, Bouza E, Aguilar L.

Antimicrob Agents Chemother. 2005 Jan;49(1):418-20.

13.

Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.

Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y, Yamamoto N, Kunishima H, Kaku M.

J Antimicrob Chemother. 2011 Mar;66(3):494-8. doi: 10.1093/jac/dkq477. Epub 2010 Dec 15.

PMID:
21172783
14.

Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.

Pires R, Ardanuy C, Rolo D, Morais A, Brito-Avô A, Gonçalo-Marques J, Liñares J, Santos-Sanches I.

Antimicrob Agents Chemother. 2010 Jun;54(6):2677-80. doi: 10.1128/AAC.01536-09. Epub 2010 Mar 29.

15.

[Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].

Zhang FF, Zhao CJ, Wang H.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Dec;36(12):940-4. Chinese.

PMID:
24503427
16.

Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes.

Duesberg CB, Malhotra-Kumar S, Goossens H, McGee L, Klugman KP, Welte T, Pletz MW.

Antimicrob Agents Chemother. 2008 Nov;52(11):4191-3. doi: 10.1128/AAC.00518-08. Epub 2008 Sep 2.

17.

The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.

Nouri R, Ahangarzadeh Rezaee M, Hasani A, Aghazadeh M, Asgharzadeh M.

Braz J Microbiol. 2016 Oct - Dec;47(4):925-930. doi: 10.1016/j.bjm.2016.07.016. Epub 2016 Jul 26.

18.

The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients.

Lautenbach E, Metlay JP, Mao X, Han X, Fishman NO, Bilker WB, Tolomeo P, Wheeler M, Nachamkin I.

Clin Infect Dis. 2010 Aug 1;51(3):280-5. doi: 10.1086/653931.

19.

Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.

Wajima T, Morozumi M, Chiba N, Shouji M, Iwata S, Sakata H, Ubukata K.

Int J Antimicrob Agents. 2013 Nov;42(5):447-9. doi: 10.1016/j.ijantimicag.2013.06.022. Epub 2013 Aug 9.

PMID:
23988719
20.

Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.

Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN.

Trans R Soc Trop Med Hyg. 2016 Aug;110(8):472-9. doi: 10.1093/trstmh/trw051. Epub 2016 Sep 12.

PMID:
27618918

Supplemental Content

Support Center